New York —

Linda Yaccarino, the former CEO of the Elon Musk-owned social media platform X, has a new leadership gig in the weight loss space.

Yaccarino on Tuesday was named the CEO of eMed, a Miami-based telehealth company that dispenses GLP-1 medications such as Wegovy and Ozempic.

The appointment marks a shift for Yaccarino, who has a background largely in marketing, advertising and media world. Prior to joining X, Yaccarino worked in various advertising and global partnerships for NBCUniversal and Turner for several decades.

In a press release , eMed said that Yaccarino is arriving in a “game-changing moment” in the company’s five-year old history, which is to “make safe, effective and sustainable chronic care accessible directly through an all-in-one, digital-first experience

See Full Page